Clarity Medical Group Holding Limited (HKG:1406)
0.3550
+0.0200 (5.97%)
Apr 14, 2025, 9:50 AM HKT
HKG:1406 Cash Flow Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -46.41 | -34.29 | -75.79 | -3.19 | 13.49 |
Depreciation & Amortization | 22.21 | 23.03 | 37.38 | 24.91 | 22.09 |
Loss (Gain) From Sale of Assets | 0.01 | -0.26 | - | - | - |
Asset Writedown & Restructuring Costs | 0.08 | 5.23 | 30.05 | 0.15 | - |
Stock-Based Compensation | 2.2 | 6.18 | 6.03 | - | - |
Other Operating Activities | -2.93 | -1.19 | -10.65 | -2.28 | -5.78 |
Change in Accounts Receivable | -0.54 | -2.14 | -0.69 | -0.86 | 0.78 |
Change in Inventory | 0.33 | 1.06 | 0.11 | 0.06 | 0.45 |
Change in Accounts Payable | 0.98 | 0.86 | -2.4 | 1.29 | -2.53 |
Change in Other Net Operating Assets | -4.31 | 19.4 | 0.39 | -3.86 | -0.96 |
Operating Cash Flow | -28.38 | 17.88 | -15.58 | 16.22 | 27.55 |
Operating Cash Flow Growth | - | - | - | -41.12% | -61.39% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -0.67 | -7.53 | -32.81 | -30.2 | -0.21 |
Sale of Property, Plant & Equipment | 0.21 | 1.37 | - | - | - |
Investment in Securities | -1.01 | 45.6 | 53 | -103 | - |
Other Investing Activities | 1.91 | 4.95 | 6.42 | 3.64 | 0.05 |
Investing Cash Flow | 0.44 | 44.39 | 26.61 | -143.76 | -0.16 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Repaid | -12.95 | -20 | -22.07 | -14.73 | -12.73 |
Lease Payments | -12.95 | -20 | -22.07 | -14.73 | -12.73 |
Total Debt Repaid | -12.95 | -20 | -22.07 | -14.73 | -12.73 |
Net Debt Issued (Repaid) | -12.95 | -20 | -22.07 | -14.73 | -12.73 |
Issuance of Common Stock | - | - | - | 10.49 | 205.54 |
Repurchase of Common Stock | - | - | - | -3.47 | - |
Common Dividends Paid | - | - | - | - | -26 |
Other Financing Activities | -0.79 | -1.04 | -2.02 | -1.53 | -17.79 |
Financing Cash Flow | -13.73 | -21.03 | -24.1 | -9.23 | 149.02 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Foreign Exchange Rate Adjustments | 0.11 | -0.09 | 0 | - | - |
Net Cash Flow | -41.57 | 41.14 | -13.07 | -136.77 | 176.41 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -29.05 | 10.34 | -48.39 | -13.98 | 27.35 |
Free Cash Flow Growth | - | - | - | - | -56.01% |
Free Cash Flow Margin | -16.34% | 5.73% | -25.35% | -6.54% | 12.14% |
Free Cash Flow Per Share | -0.05 | 0.02 | -0.09 | -0.03 | 0.07 |
Levered Free Cash Flow | -13.21 | 24.98 | -26.5 | -23.95 | 40.06 |
Unlevered Free Cash Flow | -12.71 | 25.63 | -25.24 | -22.99 | 40.54 |
Free Cash Flow After Leases | -42 | -9.65 | -70.46 | -28.71 | 14.62 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 0.79 | 1.04 | 2.02 | 1.53 | 0.78 |
Cash Income Tax Paid | - | -1.41 | 0.35 | 0.22 | 10.53 |
Change in Working Capital | -3.54 | 19.18 | -2.59 | -3.36 | -2.26 |